Skip to main content
. 2022 Dec 8;134(2):328–338. doi: 10.1152/japplphysiol.00445.2022

Table 2.

Disease characteristics and medications

Disease Characteristics n, %
 NYHA class II 10, 71
 NYHA class III 4, 29
 Diabetes 2, 14
 COPD 0, 0
 CAD 2, 14
 Hypertension 10, 71
 Hyperlipidemia 4, 29
Medications
 β-Blockers 7, 50
 ACEi 4, 29
 ARB 4, 29
 Loop diuretics 10, 71
 Aldosterone antagonists 11, 79
 Statin 8, 57
 Ca2+ channel blocker 7, 50
 Mean Rx types taken, n 3.7 ± 1.1
 Patients taking Rx, % 100

Data are means ± SD or count (%) and included n = 14 (4 M/10 F). ARB; angiotensin-receptor blockers; ACEi, angiotensin-converting enzyme inhibitors; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; NYHA, New York Heart Association.